Anti-aging & Longevity Protocol

Anti-aging & Longevity Protocol

Publications

June 23, 2026

A physician-designed longevity protocol that targets the cellular hallmarks of aging — not to chase eternal youth, but to compress morbidity and extend years of active, independent, high-function life.

At a Glance

 

What it targets: The cellular hallmarks of biological aging — mitochondrial dysfunction, NAD+ decline, growth hormone reduction, cellular senescence, and chronic inflammation.

 

Who it’s for: Adults 40-65 who want to extend their years of peak function, those with family history of age-related disease, and those who’ve noticed the first subtle markers of aging and want to intervene early with an evidence-based programme.

 

How it works: A 360-degree approach — monthly IV foundation, physician-selected peptide layers based on age and clinical picture, plus the lifestyle, supplementation, and recovery practices that determine biological-age trajectory.

 

What to expect: Energy, sleep, and recovery often improve early. Body composition, cognitive sharpness, and biological-age markers shift over the sustained phase. This is a long-game intervention, not a quick fix.

 

Who This Protocol Is For

ALIV’s Anti-aging & Longevity Protocol is for adults who take the long view on health — who want more years in active, independent, high-function life, not just more years. Many clients arrive specifically researching anti-aging treatment, peptide therapy, NAD+ therapy, biological age testing, or regenerative/stem cell options for anti-aging in India, and want a physician-supervised programme. Aging is the convergence of multiple cellular hallmarks: mitochondrial decline, telomere shortening, epigenetic drift, cellular senescence, chronic inflammation. The protocol works at the hallmarks level rather than chasing single biomarkers.

This protocol was built for you if:

  • You’re in your 40s, 50s, or 60s and want to proactively extend your years of peak function

  • Family history of age-related disease — cardiovascular, neurodegenerative, metabolic, or cancer — is a meaningful concern

  • You’ve noticed the first markers of aging — slower recovery, reduced resilience, changes in skin, sleep, or energy

  • You want a science-led, physician-supervised approach — not a wellness retreat or supplement stack promising eternal youth

  • You’ve invested in your career and family, and you want the body and mind to keep up with what you’ve built

This protocol is about physiology, not vanity. The interventions you make in your 40s and 50s determine whether your 70s and 80s are spent thriving or declining.

 

How It Works — The ALIV Approach

ALIV’s longevity approach is 360-degree — systemic and organ-related, lifestyle and recovery, immunity, stress, and the epigenetic factors shaping all of these. The cellular hallmarks of aging — catalogued in landmark reviews by López-Otín and colleagues — give us specific biological targets rather than vague ‘anti-aging’ promises.

 

Layer 1 — IV Foundation

This protocol opens with a sustained IV foundation. ALIV’s Myer’s Cocktail — vitamins (B-complex, B12, vitamin C) and minerals (magnesium, calcium) — is delivered monthly to maintain micronutrient sufficiency. Alongside it runs an introductory NAD+ infusion course as a multi-session protocol, addressing the steady NAD+ decline that drives mitochondrial dysfunction, impaired DNA repair, and reduced sirtuin signalling. After the intro course, monthly NAD+ maintenance infusions sustain the gains.

 

Layer 2 — Peptide Options

Several peptides target distinct aspects of aging biology. These are options requiring physician selection — chosen based on age, clinical picture, hormone function, and goals.

 

GHK-Cu 

A copper-binding peptide central to ALIV’s anti-aging approach. It contributes to physical and aesthetic outcomes (skin quality, wound healing, hair) while modulating thousands of genes involved in DNA repair, antioxidant defence, and tissue regeneration. The depth of its biological reach makes it one of the most important peptides at this layer.

 

Thymosin Alpha-1

A 28-amino-acid immune-modulating peptide. With age, immune surveillance and regulation both decline; Tα1 helps re-balance immunity, increasingly relevant from middle age onwards.

 

Mitochondrial peptide options — SS-31 and MOTS-c

Where mitochondrial decline dominates, Elamipretide (SS-31) stabilises the inner mitochondrial membrane and MOTS-c activates AMPK signalling. Both are investigational, with mixed clinical trial outcomes and unclear Indian regulatory status.

 

Epitalon 

A synthetic tetrapeptide with documented telomerase activation and telomere elongation in human somatic cell cultures. Epitalon can be a valuable addition for many clients, but plugging it in requires detailed evaluation — activity level, age, and hormone function all factor in. Honest framing: human in vivo trial data is limited; Epitalon is not FDA-approved.

 

Growth hormone peptide options — Sermorelin and Tesamorelin 

When GH support is indicated, Sermorelin is the gentlest way of amplifying your body’s own GH release. Tesamorelin is the alternative when visceral fat and metabolic dysfunction dominate.

 

Layer 3 — Diagnostic Precision

Before any intervention, your ALIV physician runs a comprehensive longevity workup — inflammatory markers (hsCRP, IL-6), metabolic and insulin profile, hormonal assessment, advanced lipids, micronutrient status, and where appropriate, biological-age markers.

 

What to Expect

PhaseWhat You May Notice
Early phaseEnergy, sleep quality, and recovery often shift first. Mental clarity improves. Initial inflammatory markers may begin moving.
Building phaseBody composition shifts — muscle preservation, visceral fat reduction. Skin quality and hair often improve. Cognitive stamina extends.
Sustained phaseFunctional capacity and biological-age markers continue improving. Many clients describe regaining capabilities they’d adapted around losing. The protocol shifts toward maintenance.

 

Individual outcomes vary based on baseline biological state, genetic factors, lifestyle adherence, and stage of intervention. ALIV does not guarantee specific outcomes including biological age reversal.

 

What’s Involved

Before starting, your ALIV medical team runs the diagnostic assessment described above and designs a protocol specifically for you. Contraindications are detailed in the FAQ below.

 

The Lifestyle Layer — The Foundation of Longevity

Peptides and IVs accelerate biological restoration; they cannot outrun a lifestyle that actively ages you. The lifestyle layer is the foundation, not an add-on.

 

Structured Physical Training

Exercise is the single most potent longevity intervention ever studied. Zone 2 cardio — sustained moderate-intensity aerobic work where you can hold a conversation — builds mitochondrial density and cardiovascular reserve. Resistance training preserves muscle and metabolic function. Adequate protein intake anchors both. Both modalities are non-negotiable for healthspan.

 

Nutrition for Healthspan

Whole-food eating with adequate protein, healthy fats, and polyphenol-rich vegetables is the foundation. Indian dietary patterns — dals, vegetables, paneer, fish, eggs, fermented foods — align well with longevity science when refined-carbohydrate intake is moderated.

 

Sleep, Stress, and Recovery

Sleep quality affects nearly every hallmark of aging. Chronic stress accelerates biological aging through cortisol dysregulation and direct effects on telomere length. Where sleep is disrupted, ALIV’s Sleep Protocol coordinates with this design.

 

Targeted Supplementation

Supplementation is tailored to your assessment. Common compounds include Glycine for sleep and metabolic support, NAC as a glutathione precursor, L-theanine for stress regulation, Omega-3, NMN as oral NAD+ maintenance, a regular multivitamin, and ongoing maintenance of Vitamin D3 and ferritin.

 

Relationships and Purpose

The data on social connection and sense of purpose is as strong as the data on exercise and diet. Loneliness is a measurable mortality risk factor — healthspan biology, not wellness sentiment.

 

Frequently Asked Questions

 

What’s the difference between healthspan and lifespan?

Lifespan is total years lived. Healthspan is years spent in active, independent, high-function life. The goal is to compress morbidity — reduce the years spent declining — not maximise survival at any cost.

 

Can aging be reversed?

Honestly: aging cannot be fully reversed with any current therapy. What can be done is to slow biological aging, improve cellular function, and shift trajectory — measurable through epigenetic clocks, telomere length, and inflammatory markers. Look-younger and feel-younger outcomes are realistic; eternal youth is not.

 

What is biological age, and can I test it?

Chronological age is your years lived. Biological age estimates how old your cells are functioning, measured via epigenetic clocks (Horvath, GrimAge, PhenoAge), telomere length, and biomarker panels. These tests are available in India. Knowing your biological age gives a measurable trajectory to optimise against.

 

Is stem cell therapy good for anti-aging?

Regenerative and autologous cell therapy is one of the most-researched anti-aging modalities, with growing evidence for systemic effects — immune resilience, tissue repair signalling, recovery markers. It is investigational; outcomes vary; it does not reverse aging. At ALIV it is reserved for selected clients after foundational layers are optimised.

 

Is this the same as longevity clinics in the US?

Core science is the same. ALIV draws on the same hallmarks-of-aging framework underpinning leading longevity clinics globally. Pricing, accessibility, and adaptation to the Indian context distinguish the offering.

 

Who should NOT do this protocol?

Active malignancy (some peptides work through growth-factor pathways requiring caution); significant untreated cardiovascular disease; active autoimmune flares; pregnancy or breastfeeding; clients seeking eternal-youth outcomes rather than realistic healthspan extension.

 

Take the Next Step

If you want to be functional, active, and independent at 75 and 85, not just alive, starting is the work.

To find out if the Anti-aging & Longevity Protocol is right for you, speak with our medical team:

  • Pune (Bund Garden): [clinic phone number]

  • Mumbai (Khar West): [clinic phone number]

Or book a consultation through alivtherapy.in.

 

Research References

1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217. PMID: 23746838

2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243-278. PMID: 36599349

3. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547. PMID: 29514064

4. Conlon NJ. The role of NAD+ in regenerative medicine. Plast Reconstr Surg. 2022;150(4 Suppl):41S-48S. PMID: 36170435

5. Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20. PMID: 28212278

6. Dinetz E, Lee E. Comprehensive review of the safety and efficacy of Thymosin Alpha 1 in human clinical trials. Altern Ther Health Med. 2024;30(1):6-12. PMID: 38308608

7. Birk AV, Liu S, Soong Y, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24(8):1250-1261. PMID: 23813215

8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459

9. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PMID: 33473109

10. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370. PMID: 18057338

11. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):692-695. PMID: 12937682. [In vitro cell-culture data; no human in vivo trials.]

 

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including any age-related condition. This protocol is integrative supportive care, not a replacement for specialist medical management. Outcomes vary significantly between individuals — ALIV does not guarantee specific outcomes including biological age reversal, lifespan extension, or disease prevention. Several compounds referenced (notably Epitalon, MOTS-c, SS-31) carry investigational status with limited or in vitro-only human data; the peptides used are not FDA-approved and are accessed in India via compounding pharmacies. Informed consent and physician monitoring are essential. Please consult a qualified healthcare professional before starting any therapy programme.

 

 

Get in touch

book-now